Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Cyclic - C2  (3D View)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 52882.78 
• Atom Count: 3605 
• Residue Count: 465 
• Unique protein chains: 1

3E9K

Crystal structure of Homo sapiens kynureninase-3-hydroxyhippuric acid inhibitor complex

• DOI: 10.2210/pdb3E9K/pdb

• Classification: HYDROLASE
• Organism(s): Homo sapiens
• Expression System: Escherichia coli


• Deposited: 2008-08-22 Released: 2008-12-09 
• Deposition Author(s): Lima, S., Kumar, S., Gawandi, V., Momany, C., Phillips, R.S.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.7 Å
• R-Value Free: 0.191 
• R-Value Work: 0.153 

Literature

Crystal structure of the Homo sapiens kynureninase-3-hydroxyhippuric acid inhibitor complex: insights into the molecular basis of kynureninase substrate specificity.

Lima, S., Kumar, S., Gawandi, V., Momany, C., Phillips, R.S.

(2009) J.Med.Chem. 52: 389-396

• PubMed: 19143568 
• DOI: 10.1021/jm8010806


• PubMed Abstract: 
  

Homo sapiens kynureninase is a pyridoxal-5'-phosphate dependent enzyme that catalyzes the hydrolytic cleavage of 3-hydroxykynurenine to yield 3-hydroxyanthranilate and L-alanine as part of the tryptophan catabolic pathway leading to the de novo biosynthesis of NAD(+). This pathway results in quinolinate, an excitotoxin that is an NMDA receptor agonist. High levels of quinolinate have been correlated with the etiology of neurodegenerative disorders such as AIDS-related dementia and Alzheimer's disease. We have synthesized a novel kynureninase inhibitor, 3-hydroxyhippurate, cocrystallized it with human kynureninase, and solved the atomic structure. On the basis of an analysis of the complex, we designed a series of His-102, Ser-332, and Asn-333 mutants. The H102W/N333T and H102W/S332G/N333T mutants showed complete reversal of substrate specificity between 3-hydroxykynurenine and L-kynurenine, thus defining the primary residues contributing to substrate specificity in kynureninases.

---

Organizational Affiliation: 

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, USA.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Kynureninase	A	465	Homo sapiens	Mutation(s): 0  Gene Names: KYNU EC: 3.7.1.3
Find proteins for Q16719 (Homo sapiens) Go to Gene View: KYNU Go to UniProtKB:  Q16719

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
PLP	A	PYRIDOXAL-5'-PHOSPHATE VITAMIN B6 Phosphate C8 H10 N O6 P NGVDGCNFYWLIFO-UHFFFAOYSA-N
3XH	A	3-Hydroxyhippuric acid N-[(3-hydroxyphenyl)carbonyl]glycine C9 H9 N O4 XDOFWFNMYJRHEW-UHFFFAOYSA-N

Modified Residues  1 Unique
ID	Chains	Type	Formula	2D Diagram	Parent
CSX	A	L-PEPTIDE LINKING	C3 H7 N O3 S		CYS

External Ligand Annotations
ID	Binding Affinity (Sequence Identity %)
3XH	Ki: 60000 nM (100) BINDINGDB
3XH	Ki: 60000 nM BINDINGMOAD

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.7 Å
• R-Value Free: 0.191 
• R-Value Work: 0.153 
• Space Group: C 1 2 1

Unit Cell:

Length (Å)	Angle (°)
a = 74.444	α = 90.00
b = 77.124	β = 109.35
c = 94.558	γ = 90.00

Software Package:

Software Name	Purpose
HKL-3000	data scaling
HKL-3000	data collection
REFMAC	refinement
HKL-3000	data reduction
PHASER	phasing

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2008-08-22 
• Released Date: 2008-12-09 
• Deposition Author(s): Lima, S., Kumar, S., Gawandi, V., Momany, C., Phillips, R.S.

Revision History 

• Version 1.0: 2008-12-09
  Type: Initial release
• Version 1.1: 2011-07-13
  Type: Advisory, Version format compliance